...
首页> 外文期刊>American Journal of Physiology >Ca(2+) mobilization through dorsal root ganglion Ca(2+)-sensing receptor stably expressed in HEK293 cells.
【24h】

Ca(2+) mobilization through dorsal root ganglion Ca(2+)-sensing receptor stably expressed in HEK293 cells.

机译:Ca(2+)动员通过背根神经节Ca(2+)敏感受体稳定表达在HEK293细胞中。

获取原文
获取原文并翻译 | 示例

摘要

The rat dorsal root ganglion (DRG) Ca(2+)-sensing receptor (CaR) was stably expressed in-frame as an enhanced green fluorescent protein (EGFP) fusion protein in human embryonic kidney (HEK)293 cells, and is functionally linked to changes in intracellular Ca(2+) concentration ([Ca(2+)](i)). RT-PCR analysis indicated the presence of the message for the DRG CaR cDNA. Western blot analysis of membrane proteins showed a doublet of 168-175 and 185 kDa, consistent with immature and mature forms of the CaR.EGFP fusion protein, respectively. Increasing extracellular [Ca(2+)] ([Ca(2+)](e)) from 0.5 to 1 mM resulted in increases in [Ca(2+)](i) levels, which were blocked by 30 microM 2-aminoethyldiphenyl borate. [Ca(2+)](e)-response studies indicate a Ca(2+) sensitivity with an EC(50) of 1.75 +/- 0.10 mM. NPS R-467 and Gd(3+) activated the CaR. When [Ca(2+)](e) was successively raised from 0.25 to 4 mM, peak [Ca(2+)](i), attained with 0.5 mM, was reduced by approximately 50%. Similar reductions were observed with repeated applications of 10 mM Ca(2+), 1 and 10 microM NPS R-467, or 50 and 100 microM Gd(3+), indicating desensitization of the response. Furthermore, Ca(2+) mobilization increased phosphorylated protein kinase C (PKC)alpha levels in the cells. However, the PKC activator, phorbol myristate acetate did not inhibit CaR-mediated Ca(2+) signaling. Rather, a spectrum of PKC inhibitors partially reduced peak responses to Ca(e)(2+). Treatment of cells with 100 nM PMA for 24 h, to downregulate PKC, reduced [Ca(2+)](i) transients by 49.9 +/- 5.2% (at 1 mM Ca(2+)) and 40.5 +/- 6.5% (at 2 mM Ca(2+)), compared with controls. The findings suggest involvement of PKC in the pathway for Ca(2+) mobilization following CaR activation.
机译:大鼠背根神经节(DRG)Ca(2+)感应受体(CaR)在人类胚胎肾(HEK)293细胞中稳定表达为增强的绿色荧光蛋白(EGFP)融合蛋白,并功能连接改变细胞内Ca(2+)浓度([Ca(2 +)](i))。 RT-PCR分析表明存在DRG CaR cDNA信息。膜蛋白的蛋白质印迹分析显示双链体为168-175和185 kDa,分别与CaR.EGFP融合蛋白的未成熟形式和成熟形式一致。将细胞外[Ca(2+)]([Ca(2 +)](e))从0.5增加到1 mM,导致[Ca(2 +)](i)的水平增加,被30 microM 2-阻断氨基乙基二苯基硼酸酯。 [Ca(2 +)](e)响应研究表明,Ca(2+)的灵敏度为EC(50)为1.75 +/- 0.10 mM。 NPS R-467和Gd(3+)激活了CaR。当[Ca(2 +)](e)从0.25依次提高到4 mM时,以0.5 mM达到的峰[Ca(2 +)](i)降低了约50%。重复应用10 mM Ca(2 +),1和10 microM NPS R-467或50和100 microM Gd(3+)可以观察到类似的减少,表明响应降低了灵敏度。此外,Ca(2+)动员增加细胞中的磷酸化蛋白激酶C(PKC)alpha水平。但是,PKC激活剂佛波醇肉豆蔻酸酯乙酸盐不会抑制CaR介导的Ca(2+)信号。而是,一系列PKC抑制剂部分降低了对Ca(e)(2+)的峰响应。用100 nM PMA处理细胞24小时,以下调PKC,将[Ca(2 +)](i)瞬变降低49.9 +/- 5.2%(在1 mM Ca(2+)时)和40.5 +/- 6.5 %(在2 mM Ca(2+)下),与对照组相比。研究结果表明PKC参与CaR激活后Ca(2+)动员的途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号